4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001861477-26-000003
EVP, Head of Research & Dev sold 3,435 shares at $21.47 ($73,749)
- EVP, Head of Research & Dev acquired 6,715 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thompson Elizabeth H.Z. EVP, Head of Research & Dev | 2026-03-24 | Option exercise | +6,715 | 6,715 | D | ||
| Thompson Elizabeth H.Z. EVP, Head of Research & Dev | 2026-03-25 | Sale | −3,435 | $21.47 | $73,749 | 3,280 | D |
| Derivatives | |||||||
| Thompson Elizabeth H.Z. EVP, Head of Research & Dev | 2026-03-24 | Option exercise · Restricted Stock Units | −6,715 | 20,146 | D | ||
| Open-market sales · 3,435 sh · avg $21.47 · $73,749 | |||||||
Loading xslF345X06/form4-03262026_080306.xml…